STOUGHTON, Mass. - Collegium Pharmaceutical , Inc. (NASDAQ:COLL), a diversified biopharmaceutical company with a market capitalization of nearly $1 billion and impressive gross profit margins of 87%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback